7
FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK 14bis Sh MAPK 11 Sh MAPK 12 Sh MAPK 13 IC50 (nM) HCT116-TP53KO HA MAPK14 CA MAPK11 CA MAPK12 CA MAPK13CA tubulin HCT116-TP53KO D Kinase Assay 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 EV MAPK 14 CA MAPK 11 CA MAPK 12 CA MAPK 13 CA IC50 (nM) HCT116-TP53KO E pp38 GAPDH HCT116-TP53KO NT SN38 F C p ATF2 MAPK14 CA MAPK11 CA MAPK12 CA MAPK13CA

FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

Embed Size (px)

Citation preview

Page 1: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 1A

p38

EVSh

MAPK14

HCT116-TP53KO

GAPDH

EV EVSh

MAPK14bis

ShMAPK

12

ShMAPK

13EV

ShMAPK

11

B

0.0

0.5

1.0

1.5

2.0

2.5

ShLUC

ShMAPK

14

ShMAPK14bis

ShMAPK

11

ShMAPK

12

ShMAPK

13

IC50

(nM

)

HCT116-TP53KO

HA

MA

PK

14 C

A

MA

PK

11 C

A

MA

PK

12 C

A

MA

PK

13C

A

tubulin

HCT116-TP53KO

D Kinase Assay

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

EVMAPK

14CA

MAPK11CA

MAPK12CA

MAPK13CA

IC50

(nM

)

HCT116-TP53KO

Epp38

GAPDH

HCT116-TP53KO

NT SN38F

C

p ATF2

MA

PK

14 C

A

MA

PK

11 C

A

MA

PK

12 C

A

MA

PK

13C

A

Page 2: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 2A

0

1

2

3

4

0 2 4 6 8 10 12

HCT116-TP53KO EV

HCT116-TP53KO-MAPK14CAC

ell n

umbe

r (1

06 )

Days

B

Dou

blin

g T

ime

(hou

rs)

020406080

100120

EV MAPK14-CA

HCT116-TP53KO

HCT116-TP53KO-EV

HCT116-TP53KO-MAPK14CA

0

20

40

60

80

100

120

D7 D14 D21 D28

% li

vin

g c

ells

CHCT116-TP53 KO

0

5

10

15

20

EVMAPK14

CA

% A

PO

PT

OS

IS

D

EHCT116-TP53KO-EV HCT116-TP53KO-MAPK14CA

0

1

2

3

4

5

HCT116-TP53KO

-EV

HCT116-TP53KO-

MAPK14CA

Blu

e ce

ll nu

mbe

r/fie

ld

Page 3: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 3

AHCT116-TP53KO-EV HCT116-TP53KO-MAPK14CA

S49.4%

G0G1

28.8%

G2/M18.4%

S37.1%

G0G1

36.8%

G2/M19.3%

B

0

20

40

60

80

100

120

0 5 10 15 20 25 30

HCT116-TP53KO-EV

HCT116-TP53KO-MAPK14CA

% o

f Brd

U s

tain

ed c

ells

D

0.0

0.2

0.4

0.6

0.8

1.0

1.2

EVD7 D14 D21 D28

p21

Arb

itrar

y R

NA

uni

ts

MAPK14CA

HCT116-TP53KO

C

p21

Actin

EVD7 D14 D21 D28

MAPK14CA

HCT116-TP53KO

HA

p21

shLUC shp21

HCT116-TP53KO-MAPK14CA

GAPDH

E

HCT116-TP53KO-ShLuc-MAPK14CA

HCT116-TP53KO-Shp21-MAPK14CA

S25.8%

G0G1

45.6%

G2/M23.16%

S46.1%

G0G1

20.9%G2/M28.9%

F G

0102030405060708090

0 5 10 15 20 25 30

HCT116-TP53KO-ShLuc-MAPK14CA

HCT116-TP53KO-Shp21-MAPK14CA

% o

f Brd

U s

tain

ed c

ells

Page 4: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 4A

HCT116-TP53KO

EV MAPK14CALC3

Actin

EVD7 D14 D21 D28

MAPK14CA

HCT116-TP53KO

H1299

LC3

Tubulin

EV D7 D14 D21

MAPK14CA

B

C

500 nm500 nm

HCT116-TP53KO

EV MAPK14CA

Aut

op

ha

goso

me

nu

mb

er/

cell

MAPK14CAEV

HCT116-TP53 KO

0123456

D

HCT116-TP53 KO

MAPK14CAEV

GFP-LC3 labelling

10-

8 -

6 -

4 -

2 -

0 -

EHCT116-TP53KO-

MAPK14CA

GAPDH

LC3

shLUC shp21

HCT116-TP53KO

GF

P-L

C3

spot

s/ce

ll

EV MAPK14CA

Page 5: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 5

p62

Actin

EV D7 D14 D21 D28

MAPK14CA

HCT116-TP53KOA

0

1

2

EV D7 D14 D21 D28

p62

leve

l(a

rbitr

ary

unit)

MAPK14CA

HCT116-TP53KO

B HCT116-TP53KO (J14)

p62

NT 2H 4H 8H NT 2H 4H 8H

EV MAPK14CA

GAPDH

0

40

80

120

160

nt 2h 4h 8h nt 2h 4h 8h

p62

leve

l(a

rbitr

ary

unit)

EV

HCT116-TP53KO

MAPK14CA

NT 3MA Baf NT Baf 3MA

LC3

Actin

EV

HCT116-TP53KO

MAPK14CA D14

HCT116-TP53KO

EV MAPK14CA D14

0

0.5

1

1.5

2

2.5

3

NT 3MA Baf NT 3MA Baf

LC3-

II le

vel

(arb

itrar

y un

it)C

D E

Atg7

Actin

HCT116-TP53KO

Atg5

siCT D2 D4

siRNA

NT 3MA Baf NT 3MA Baf

HCT116-TP53KO

EV MAPK14CA D14

Cel

l via

bilit

y (%

)

0

20

40

60

80

100

HCT116-TP53KO

EV MAPK14CA D14

Cel

l via

bilit

y (%

)

0

20

40

60

80

100

siC

T

siA

tg 5

siA

tg 7

siC

T

siA

tg 5

siA

tg 7

Page 6: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 6

A LC3 labelling

HCT116-TP53 KO

SN38

NT

LC3

spot

s/ce

ll

012

34

56

7

NT SN38

HCT116-TP53KO

B

NT SN

HCT116TP53KO

LC3

Actin

NT SN

SW480

LC3

Actin

C

SN38SN+

Baf

SN+

3MA

LC3

GAPDH

HCT116-TP53KO

D

siCT siAtg5 siAtg7

SW480

SN

38 IC

50 (

nM)

0

2

4

6

8 Cytotoxic Assay

E F

siCT siAtg5 siAtg7

4

3

2

1

0

HCT116-TP53KO

SN

38 IC

50 (

nM) Cytotoxic Assay

0

0.4

0.8

1.2

1.6

siCT siATG5 siATG7

HCT116-TP53KO

SN

38 IC

50 (

nM) Clonogenic Assay

HCT116-TP53KO

0

20

40

60

80

100

120

NT SN38 SN38+3MA

% li

ving

cel

ls

G

Page 7: FIGURE 1 A p38 EV Sh MAPK 14 HCT116-TP53KO GAPDH EV Sh MAPK 14bis Sh MAPK 12 Sh MAPK 13 EV Sh MAPK 11 B 0.0 0.5 1.0 1.5 2.0 2.5 Sh LUC Sh MAPK 14 Sh MAPK

FIGURE 7

LC3

MAPK14

Actin

NT SN SN+3MA NT SN SN+3MA

HCT116-TP53KO-shLUC

HCT116-TP53KO-shMAPK14A

B

shLUC shMAPK

11

shMAPK

12

shMAPK

13

shLUC shMAPK

11

shMAPK

12

shMAPK

13

LC3

HCT116-TP53KO

GAPDH

NT SN38

0

1

2

3

HCT116-TP53KOShLuc

HCT116-TP53KOShMAPK14

SN38SN38+3MA

SN

38 IC

50 (

nM)C

D

siCT

siATG5

siATG7

0

1

2

3

HCT116-TP53KO ShLuc

SN

38 IC

50 (

nM)

HCT116-TP53KOShMAPK14